BillionToOne (BLLN) Price to Earnings (2025 - 2026)

BillionToOne's (BLLN) quarterly Price to Earnings came in at 697.57 in Q2 2026, up 245.35% quarter-over-quarter from 201.99 in Q1 2026.

Analysis

BillionToOne (BLLN) Price to Earnings (2025 - 2026) Analysis & Trends

BillionToOne has disclosed Price to Earnings across 2 years of filings, most recently posting 697.57 for Q2 2026.

In Q2 2026, Price to Earnings changed N/A year-over-year to 697.57; the TTM figure through Jun 2026 stood at 186.89 (changed N/A YoY), while the FY2025 annual figure was 1284.23, changed N/A from the prior year.
Price to Earnings came in at 697.57 for Q2 2026 at BillionToOne, up from 201.99 in the prior quarter.
In the past five years, Price to Earnings ranged from a high of 1481.1 in Q4 2025 to a low of 201.99 in Q1 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Natera	47.13 Bn	46.03 Bn	486.15 Mn
2	Labcorp Holdings	26.44 Bn	26.32 Bn	1.11 Bn
3	Quest Diagnostics	26.16 Bn	25.84 Bn	1.03 Bn
4	Guardant Health	21.57 Bn	20.51 Bn	219.03 Mn
5	Tempus AI	11.32 Bn	10.51 Bn	274.25 Mn
6	Caris Life Sciences	7.08 Bn	6.29 Bn	182.38 Mn
7	Sotera Health	5.39 Bn	5.04 Bn	177.96 Mn
8	BillionToOne	4.65 Bn	4.11 Bn	77.11 Mn
9	iRhythm Holdings	4.05 Bn	3.46 Bn	163.21 Mn
10	Adaptive Biotechnologies	3.86 Bn	3.53 Bn	51.39 Mn

Historic Data

Download Data